Total Payments
$2,640
2024 Payments
$15.00
Companies
8
Transactions
131
Medicare Patients
323
Medicare Billing
$44,325
Payment Breakdown by Category
Food & Beverage$2,640 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,640 | 131 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $594.26 | 13 | $0 (2023) |
| Alkermes, Inc. | $461.40 | 25 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $433.83 | 14 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $415.15 | 30 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $268.89 | 18 | $0 (2020) |
| Lundbeck LLC | $258.77 | 17 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $166.52 | 11 | $0 (2024) |
| AbbVie Inc. | $41.31 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15.00 | 1 | Janssen Pharmaceuticals, Inc ($15.00) |
| 2023 | $578.68 | 11 | Teva Pharmaceuticals USA, Inc. ($478.76) |
| 2022 | $37.17 | 3 | Janssen Pharmaceuticals, Inc ($13.40) |
| 2021 | $13.06 | 1 | AbbVie Inc. ($13.06) |
| 2020 | $190.06 | 6 | Neurocrine Biosciences, Inc. ($128.59) |
| 2019 | $545.62 | 31 | Neurocrine Biosciences, Inc. ($159.92) |
| 2018 | $454.53 | 35 | Sunovion Pharmaceuticals Inc. ($115.13) |
| 2017 | $806.01 | 43 | Alkermes, Inc. ($302.75) |
All Payment Transactions
131 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/27/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Neuroscience | ||||||
| 06/22/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Neuropsychiatry | ||||||
| 06/14/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $107.63 | General |
| Category: Central Nervous System | ||||||
| 05/25/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $117.18 | General |
| Category: Neurology | ||||||
| 05/15/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: CNS | ||||||
| 05/10/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $116.96 | General |
| Category: Central Nervous System | ||||||
| 05/09/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Central Nervous System | ||||||
| 03/30/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $120.29 | General |
| Category: Central Nervous System | ||||||
| 03/30/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Neuropsychiatry | ||||||
| 03/27/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Neuroscience | ||||||
| 03/20/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Neuropsychiatry | ||||||
| 11/03/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: Neuropsychiatry | ||||||
| 09/29/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA, INVEGA | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Neuroscience | ||||||
| 03/14/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2020 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $6.53 | General |
| Category: NEUROLOGY | ||||||
| 03/05/2020 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $122.06 | General |
| Category: NEUROLOGY | ||||||
| 03/04/2020 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Central Nervous System | ||||||
| 02/18/2020 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: PSYCHIATRY | ||||||
| 01/27/2020 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA, SPRAVATO | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Neuroscience | ||||||
| 01/06/2020 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.85 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $129.43 | General |
| Category: NEUROLOGY | ||||||
| 12/04/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Central Nervous System | ||||||
| 11/20/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $7.58 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 74 | 124 | $23,400 | $8,247 |
| 2022 | 3 | 142 | 300 | $54,702 | $22,253 |
| 2021 | 3 | 107 | 174 | $31,230 | $13,826 |
Total Patients
323
Total Services
598
Medicare Billing
$44,325
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 53 | 100 | $16,200 | $5,479 | 33.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 21 | 24 | $7,200 | $2,768 | 38.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 51 | 121 | $19,602 | $9,703 | 49.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 39 | 55 | $16,500 | $7,173 | 43.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 52 | 124 | $18,600 | $5,378 | 28.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 37 | 65 | $10,530 | $4,928 | 46.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 44 | 80 | $12,000 | $4,521 | 37.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 26 | 29 | $8,700 | $4,377 | 50.3% |
About Dr. Norma Talbo, MD
Dr. Norma Talbo, MD is a Psychiatry healthcare provider based in Montville, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1316097918.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Norma Talbo, MD has received a total of $2,640 in payments from pharmaceutical and medical device companies, with $15.00 received in 2024. These payments were reported across 131 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($2,640).
As a Medicare-enrolled provider, Talbo has provided services to 323 Medicare beneficiaries, totaling 598 services with total Medicare billing of $44,325. Data is available for 3 years (2021–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Montville, NJ
- Active Since 01/12/2007
- Last Updated 03/22/2013
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1316097918
Products in Payments
- INGREZZA (Drug) $433.83
- LATUDA (Drug) $415.15
- AUSTEDO (Drug) $369.45
- Aristada 441 mg (Drug) $338.96
- REXULTI (Drug) $230.17
- INVEGA SUSTENNA (Drug) $166.52
- ABILIFY MAINTENA (Drug) $133.45
- TRINTELLIX (Drug) $123.66
- UZEDY (Drug) $117.18
- Austedo XR (Drug) $107.63
- ARISTADA (Drug) $73.40
- VRAYLAR (Drug) $41.31
- BRINTELLIX (Drug) $40.38
- Vivitrol 380 mg (Drug) $24.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.